Matches in Wikidata for { <http://www.wikidata.org/entity/Q92827843> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q92827843 description "article scientifique publié en 2019" @default.
- Q92827843 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92827843 description "scientific article published on 23 July 2019" @default.
- Q92827843 description "wetenschappelijk artikel" @default.
- Q92827843 description "наукова стаття, опублікована 23 липня 2019" @default.
- Q92827843 name "Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias" @default.
- Q92827843 name "Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias" @default.
- Q92827843 type Item @default.
- Q92827843 label "Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias" @default.
- Q92827843 label "Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias" @default.
- Q92827843 prefLabel "Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias" @default.
- Q92827843 prefLabel "Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias" @default.
- Q92827843 P1433 Q92827843-A3DE0E98-136B-4E04-AE84-B67215D00E8A @default.
- Q92827843 P1476 Q92827843-683C4EB8-C351-4E27-9F7B-4EBC835C5F64 @default.
- Q92827843 P2093 Q92827843-DCB51E74-E3E0-44A7-8EC5-57B96EED0C38 @default.
- Q92827843 P304 Q92827843-B1326DB2-50A5-4FAB-A3F5-0E41C994CF80 @default.
- Q92827843 P31 Q92827843-2F941F8D-7DB9-4762-8968-61B76077D950 @default.
- Q92827843 P31 Q92827843-3d608ed0-e276-4f01-a0b5-4790f7375c15 @default.
- Q92827843 P356 Q92827843-5182E06D-EA93-4E59-8C58-E44C45B31974 @default.
- Q92827843 P478 Q92827843-C6ED4FA6-6FCB-476F-B4B0-254659718AAB @default.
- Q92827843 P577 Q92827843-6B2278DB-7669-4668-BD70-F59F152269A5 @default.
- Q92827843 P698 Q92827843-E53D4E24-BF4F-46B9-8F06-9A267B1420E8 @default.
- Q92827843 P921 Q92827843-83C75F88-AB41-4381-950E-17BA2A31A12A @default.
- Q92827843 P356 J.MEHY.2019.109314 @default.
- Q92827843 P698 31443750 @default.
- Q92827843 P1433 Q5558534 @default.
- Q92827843 P1476 "Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias" @default.
- Q92827843 P2093 "Abdulla A-B Badawy" @default.
- Q92827843 P304 "109314" @default.
- Q92827843 P31 Q13442814 @default.
- Q92827843 P31 Q7318358 @default.
- Q92827843 P356 "10.1016/J.MEHY.2019.109314" @default.
- Q92827843 P478 "131" @default.
- Q92827843 P577 "2019-07-23T00:00:00Z" @default.
- Q92827843 P698 "31443750" @default.
- Q92827843 P921 Q238474 @default.